This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 718 p35; 803111827
Reference
NICE. NICE issues final draft guidance on pomalidomide for blood cancer. Media Release : 13 Feb 2015. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Pomalidomide not recommended by NICE. PharmacoEcon Outcomes News 722, 35 (2015). https://doi.org/10.1007/s40274-015-1941-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1941-0